WOBURN, January 17, 2013 — Allergan, Inc. (NYSE: AGN) recently added 10,000 square feet to its facility at 200 Boston Ave. in Medford. The international healthcare company now occupies a total of 37,000 square feet of first-class office and laboratory space at the Cummings Properties-managed building.

California-based Allergan acquired local firm Serica Technology in 2010, and opted to retain its Medford location. Originally named Tissue Regeneration by founder and Tufts University alum Greg Altman, the firm has expanded four times since leasing 2,000 square feet at the same site in 2003.

Allergan develops and commercializes pharmaceutical products and medical devices such as Botox, Restasis, and Lap Band. The Medford facility is focused on the development and manufacturing of SeriScaffold, a surgical mesh made out of a proprietary silk-based material.

Allergan’s new space translates to greater research, development, and manufacturing capabilities for this new product, expected to be available commercially sometime this year.

According to Cummings Properties’ senior account manager, Tony Spencer, Allergan’s expansion space is part of a four-story, 35,000-square-foot addition, slated for completion this month.

Spencer said, “The timing was ideal, as Allergan’s growth coincided with our planned growth for the building. We were delighted to be able to accommodate its needs with brand new, first-class space.”

Spencer noted that nearly 90 percent of the addition had been pre-leased. Allergan, Tufts University, and agricultural biotech firm Agrivida will each occupy an entire floor of the new space.

Founded in 1969, Cummings Properties leases and manages 10 million square feet of prime commercial space in 10 suburban Boston communities. Additional information is available at www.CummingsProperties.com.